Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / articles / HHS - DEA To Congress: We Hold 'Final Authority' On Cannabis Rescheduling Overruling Biden's Health Authorities | Benzinga


HHS - DEA To Congress: We Hold 'Final Authority' On Cannabis Rescheduling Overruling Biden's Health Authorities | Benzinga

The Drug Enforcement Administration (DEA) told House lawmakers that the agency is "now conducting its review” of marijuana as a Schedule 1 drug, according to a letter obtained by Punchbowl News.

What Happened: The fate of marijuana's federal classification hangs in the balance as the DEA asserts its "final authority" on rescheduling, regardless of an August letter recommending that it reclassify cannabis from a Schedule I to a Schedule III substance.

Once the HHS made its recommendation, according to the letter, which was sent last month, "DEA conducts its own review,” reported Punchbowl.

"DEA has the final authority to schedule, reschedule, or deschedule a drug under the Controlled Substances Act, after considering the relevant statutory and regulatory criteria and HHS’s ...

Full story available on Benzinga.com

Stock Information

Company Name: Harte-Hanks, Inc.
Stock Symbol: HHS
Market: NYSE
Website: hartehanks.com

Menu

HHS HHS Quote HHS Short HHS News HHS Articles HHS Message Board
Get HHS Alerts

News, Short Squeeze, Breakout and More Instantly...